Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f98e77d1aba3a9c2fb565cc42cc7c76f |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-11 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-113 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113 |
filingDate |
2008-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2014-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4fe45acededa0c4aa81f72a0e5077f93 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7dfccfec92e11f197ce30ad732eea38a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fcc2ace855a3eb3e559e3e640a9e4a90 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_37c3804f3dedefe015fe5857ab83fb99 |
publicationDate |
2014-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
AU-2008228243-B2 |
titleOfInvention |
RNA antagonist compounds for the inhibition of Apo-B100 expression |
abstract |
Short oligonucleotides directed against the Apo-B100 gene are provided for modulating the expression of Apo-B100. Methods of using these compounds for modulation of Apo-B100 expression and for the treatment of diseases associated with Apo-B100 expression are provided. The oligonucleotides comprise deoxyribonucleosides and locked nucleic acids. |
priorityDate |
2007-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |